Standaard Boekhandel gebruikt cookies en gelijkaardige technologieën om de website goed te laten werken en je een betere surfervaring te bezorgen.
Hieronder kan je kiezen welke cookies je wilt inschakelen:
Technische en functionele cookies
Deze cookies zijn essentieel om de website goed te laten functioneren, en laten je toe om bijvoorbeeld in te loggen. Je kan deze cookies niet uitschakelen.
Analytische cookies
Deze cookies verzamelen anonieme informatie over het gebruik van onze website. Op die manier kunnen we de website beter afstemmen op de behoeften van de gebruikers.
Marketingcookies
Deze cookies delen je gedrag op onze website met externe partijen, zodat je op externe platformen relevantere advertenties van Standaard Boekhandel te zien krijgt.
Je kan maximaal 250 producten tegelijk aan je winkelmandje toevoegen. Verwijdere enkele producten uit je winkelmandje, of splits je bestelling op in meerdere bestellingen.
Local anesthetics have been called "dentistry's most important drug" for pain control which is being widely used in oral surgery, affording comfort and safety for both the patient and operator when used correctly. The choice of anesthetic solution is based on few important considerations like: potency, latency, duration, pharmacokinetics and toxicity. Lidocaine synthesized by Lofgren in 1943 was the fist amide prepared. Lidocaine is most widely used for pain control because of its pharmacokinetic characteristics and low toxicity compared with other type of local anesthetics. This make it safe for use in dental practice. Articaine HC1 was synthesized by Rusching et al. in 1969 and was first marketed in Germany in 1969 with the name Carticaine. By 1983 the drug was available in all of Europe and Canada," and was approved in US in 2000 and is available as a 4% solution with epinephrin 1:100000. The present study was undertaken to compare the anesthetic efficacy of 4% articaine with epinephrine (1:1,00,000) versus 2% lidocaine with epinephrine (1:1,00,000) during minor oral surgical procedures.